Trial Profile
A Phase II Study Of Epothilone B Analog BMS 247550 [ixabepilone] (NSC710428) In Stage IV Malignant Melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2010
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2007 Status change from in progress to completed.
- 26 Sep 2005 New trial record.